Algorae Pharmaceuticals Limited
LVCLF · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $469 | $3,108 | $4,111 | $4,239 |
| Short-Term Investments | $1,850 | $0 | $0 | $0 |
| Receivables | $4 | $29 | $10 | $30 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $76 | $55 | $86 | $0 |
| Total Curr. Assets | $2,399 | $3,193 | $4,207 | $4,269 |
| Property Plant & Equip (Net) | $0 | $0 | $5 | $5 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $0 | $0 | $5 | $5 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $2,399 | $3,193 | $4,212 | $4,274 |
| Liabilities | – | – | – | – |
| Payables | $69 | $117 | $184 | $47 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $101 | $62 | $266 | $192 |
| Total Curr. Liab. | $170 | $178 | $450 | $239 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $170 | $178 | $450 | $239 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $81,541 | $81,541 | $80,239 | $78,950 |
| Retained Earnings | -$79,885 | -$79,084 | -$80,728 | -$78,744 |
| AOCI | $573 | $557 | $4,251 | $3,829 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | $2,229 | $3,014 | $3,762 | $4,035 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $2,399 | $3,193 | $4,212 | $4,274 |
| Net Debt | -$469 | -$3,108 | -$4,111 | -$4,239 |